GE Healthcare buys Xcellerex

GE Healthcare is taking over Xcellerex, a supplier of biomanufacturing technologies, to expand its antibodies and vaccines offerings. This is the first time GE has made an acquisition in the bioprocessing sector since August 2011, when it bought PAA Laboratories. Jeffries was the sell-side adviser to Xcellerex, its seventh mandate in the past year in the life sciences sector.